Aarti Pharmalabs Limited (AARTIPHARM) — Board Meeting | 7 August 2026(2 announcements)

Aarti Pharmalabs announced that Non-Executive Director Rajendra Gogri will not seek reappointment at the upcoming AGM, ending his tenure after serving until the meeting's close. The filing confirms his departure aligns with routine rotation rules and personal commitments, with no successor named yet.

Aarti Pharmalabs announced its August 7, 2026 board meeting outcome, approving unaudited standalone and consolidated financial results for Q1 FY2026, promoting Rashesh Gogri to Managing Director and Hetal Gogri Gala to Executive Director effective October 1, 2026 pending shareholder approval at the upcoming AGM, and sanctioning a Rs.149 Crores capex for intermediate block capacity expansion. The board also reconstituted key committees including Audit, CSR, and Stakeholders Relationship Committees. The filing includes audited financial disclosures, restated prior period figures due to foreign exchange derivative adjustments, and regulatory compliance under SEBI LODR.